Dexlansoprazole Capsule, Delayed Release
Product Images NDC 24979-001

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 24979-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dexlansoprazole 01)

Chemical structure of dexlansoprazole, the active ingredient in Dexlansoprazole delayed release capsules. The diagram displays the molecular framework including a pyridine ring and a benzimidazole structure with pertinent functional groups indicated.*

FDA Label Image

Figure 1 (Dexlansoprazole 02)

A line graph showing plasma concentration of dexlansoprazole over time for 30 mg and 60 mg doses. The x-axis represents time in hours (0 to 24), and the y-axis shows plasma concentration in ng/mL (0 to 1200). Two curves illustrate concentration changes for 30 mg and 60 mg delayed release capsules, indicating pharmacokinetic profiles.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Dexlansoprazole Delayed-Release Capsules 30 mg in a package containing 30 capsules. The label shows the product name and strength, directions for storage, dispensing instructions, and manufacturer information for TWi Pharmaceuticals. The label also includes the NDC 24979-001-06, a barcode, and a pharmacist instruction to dispense an enclosed medication guide.*

FDA Label Image

Principal Display Panel (60 mg Capsule Bottle Label)

Label of Dexlansoprazole delayed-release capsules showing 60 mg strength. The label includes storage instructions, dosage information to refer to the package insert, and dispensing guidance for pharmacists. It specifies the package contains 30 capsules and lists the manufacturer as TWi Pharmaceuticals USA, Inc. and TWi Pharmaceuticals, Inc., Taiwan. The NDC number 24979-002-06 is displayed along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.